IP Verse

Graf Von Stosch, Andreas opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Cross Reactive Siglec Antibodies

Applicant:

Opposition Date:

Aug 3, 2021

Patent Number:

Title:

Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha Complexes

Applicant:

Opposition Date:

Mar 19, 2020

Patent Number:

Title:

Improved Cell Cultivation Process

Applicant:

Opposition Date:

Aug 7, 2018

Patent Number	Title	Applicant	Opposition Date
EP3191517	Cross Reactive Siglec Antibodies	INNATE PHARMA	Aug 3, 2021
EP2911684	Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha Complexes	ADMUNE THERAPEUTICS LLC	Mar 19, 2020
EP2563906	Improved Cell Cultivation Process	NOVARTIS AG	Aug 7, 2018

NOVARTIS AG

ADMUNE THERAPEUTICS LLC

INNATE PHARMA

Feel free to send us a message here and we will get back to you